Meet the Responsum Team: A Conversation with Founder and CEO Andy Rosenberg
[vc_row][vc_column][vc_column_text] As Responsum Health continues to grow our participant communities, develop more platforms and create a larger footprint in the digital health literacy and support space, we wanted to introduce potential partners and allies to the
Get Involved and Show Your Support during Pain Awareness Month 2021
September marks Pain Awareness Month, a 30-day awareness initiative that examines the role of chronic and acute pain in the proliferation of illness and the disruption of quality of life of those who struggle with
Responsum Health Raises First Round of Funding in Republic Investment Campaign
It’s an incredibly exciting time here at Responsum Health! We are pleased and delighted to announce that we have reached a critical milestone in our private investment campaign on the Republic platform. As of yesterday,
Responsum Health Launches 2021 Republic Fundraising Campaign
Responsum Health is pleased and excited to announce the launch of our inaugural fundraising campaign with partnership and support from the nation’s leading crowdsourcing investment platform, Republic. In an effort to connect with more patients,
Responsum Health Observes National Immunization Awareness Month
August is National Immunization Awareness Month, an annual event meant to highlight the importance of vaccination for people of all ages. The Centers for Disease Control and Prevention (CDC) offers a comprehensive array of resources for patients,
Welcome to Responsum for Long COVID
Today marks the official launch of our newest platform, Responsum for Long COVID. This free knowledge and empowerment platform provides personalized patient information, resources, and support for people with long COVID—i.e., those who are experiencing
Responsum Health Announces New Partnership with Black Women’s Health Imperative for Fibroids App
Responsum Health has the honor of partnering up with the Black Women’s Health Imperative (BWHI), “the only national organization dedicated solely to improving the health and wellness of our nation’s 21 million Black women and
2020: Thoughts on a Trying Year
As this most unfortunate year comes to a close, I feel a true mixture of sadness and hope. 2020 will forever be known as the year of the coronavirus, which has brought devastation and horror
New Initiative To Raise Awareness and Support Patient Recruitment for Idiopathic Pulmonary Fibrosis Clinical Trial
Update, Feb. 10, 2021: “Galapagos NV and Gilead Sciences today announced the decision to halt the ISABELA Phase 3 clinical studies with the investigational autotaxin inhibitor ziritaxestat in patients with idiopathic pulmonary fibrosis. The decision